Original Article

Predictive Value of Serum Calprotectin Level in Response to Treatment, a New Inflammatory Marker in Patients with Breast Cancer Requesting Neoadjuvant Treatment
  • Ece BAYDAR
  • Aliye ÇELİKKOL
  • Sibel ÖZKAN GÜRDAL
  • Selçuk ŞEBER
Namik Kemal Med J 2023; 11: 12-16 DOI: 10.4274/nkmj.galenos.2023.61587
Survival Outcomes and Prognostic Factors in Salivary Gland Cancers Treated by Surgery and Adjuvant Radiotherapy
  • Mürsel DÜZOVA
  • Tahir Sedat TURKAN
Namik Kemal Med J 2021; 9: 108-115 DOI: 10.4274/nkmj.galenos.2021.21931
Clinicopathological Factors Determining the Pathological Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer
  • Abdullah Evren YETİŞİR
  • Semra PAYDAŞ
Namik Kemal Med J 2021; 9: 179-183 DOI: 10.4274/nkmj.galenos.2021.32932
Effects of COVID-19 Pandemic on Diagnosis-treatment Process in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
  • Eyyüp ÇAVDAR
  • Yakup İRİAĞAÇ
  • Kubilay KARABOYUN
  • Okan AVCI
  • Erdoğan Selçuk ŞEBER
Namik Kemal Med J 2021; 9: 255-260 DOI: 10.4274/nkmj.galenos.2021.69775

Case Report

Primary Cervical Spinal Osteosarcoma Invading the Ligamentum Flavum: Case Report
  • Numan KARAARSLAN
  • Tezcan ÇALIŞKAN
  • Abdullah Talha ŞİMŞEK
Namik Kemal Med J 2017; 5: 127-130

Research Article

Mean Platelet Volume (MPV) For Predicting Prognosis of Rectum Cancer After Neoadjuvant Treatment
  • Atakan DEMİR
  • Özkan ALAN
Namik Kemal Med J 2019; 7: 279-286
Adjuvant Chemoradiation for Gastric Cancer: a Single-Center Experience
  • Ahmet YOLCU
  • Haldun Şükrü ERKAL
  • Meltem SERİN
Namik Kemal Med J 2020; 8: 351-360 DOI: 10.37696/nkmj.687778